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Background: Urban sprawl has the potential to influence cancer mortality via direct and indirect effects on obesity,
access to health services, physical activity, transportation choices and other correlates of sprawl and urbanization.
Methods: This paper presents a cross-sectional analysis of associations between urban sprawl and cancer mortality
in urban and suburban counties of the United States. This ecological analysis was designed to examine whether
urban sprawl is associated with total and obesity-related cancer mortality and to what extent these associations
differed in different regions of the US. A major focus of our analyses was to adequately account for spatial
heterogeneity in mortality. Therefore, we fit a series of regression models, stratified by gender, successively testing
for the presence of spatial heterogeneity. Our resulting models included county level variables related to race,
smoking, obesity, access to health services, insurance status, socioeconomic position, and broad geographic region
as well as a measure of urban sprawl and several interactions. Our most complex models also included random
effects to account for any county-level spatial autocorrelation that remained unexplained by these variables.
Results: Total cancer mortality rates were higher in less sprawling areas and contrary to our initial hypothesis; this
was also true of obesity related cancers in six of seven U.S. regions (census divisions) where there were statistically
significant associations between the sprawl index and mortality. We also found significant interactions (p < 0.05)
between region and urban sprawl for total and obesity related cancer mortality in both sexes. Thus, the association
between urban sprawl and cancer mortality differs in different regions of the US.
Conclusions: Despite higher levels of obesity in more sprawling counties in the US, mortality from obesity related
cancer was not greater in such counties. Identification of disparities in cancer mortality within and between
geographic regions is an ongoing public health challenge and an opportunity for further analytical work identifying
potential causes of these disparities. Future analyses of urban sprawl and health outcomes should consider
exploring regional and international variation in associations between sprawl and health.
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Urban areas are growing rapidly in population and land
area throughout the world [1]. Much of this growth falls
into a pattern characterized as ‘urban sprawl’ [2], an eco-
nomic and social process associated with low residential
density, segregation of land use, and automobile depend-
ence [3]. A number of studies have reported that urban
sprawl is associated with health outcomes, health behav-
iors, and obesity [3-7]. In cross-sectional studies, greater
levels of urban sprawl are associated with increased obes-
ity, poorer mental health, more traffic accidents, and lower
levels of physical activity including walking [4,5,8-11].
These adverse associations with health could be due to
increased exposure to pollution, changes in behaviors
that directly influence disease risk such as smoking,
sedentary time, or social behavior, or through the asso-
ciation of sprawl with use of health care systems [12].
Alternatively, selection of residential environments be-
cause of preference or economic constraints could also
produce some of these associations. Two studies, one of
childhood obesity [13] and one of walking in adults [9]
report statistically significant associations between sprawl
and energy balance outcomes in cross-sectional analyses
but not in longitudinal ones.
Research on urban sprawl has been particularly prom-
inent in the United States, in part because this kind of
development has been very common, notably in the past
30 years [14]. However, international interest in the en-
vironmental and health consequences of sprawl is also
increasing [15,16]. Independent of the analysis of urban
sprawl, there is also a long and global history of examin-
ing the effect of cities and residence in urban areas on
health outcomes, including cancer [17-19]. In the 19th
century, scrotal cancer was associated with soot expos-
ure [20] and more recently, breast and lung cancer rates
have sometimes but been reported to be higher in urban
areas than rural or suburban areas [21-24]. Wilson and
Chakraborty [25] highlight the lack of comparative studies
across national boundaries concerning the environmental
consequences of sprawl and such studies of health out-
comes and health behaviors are also rare [25]. Compara-
tive studies of urban sprawl and health could lead to
insights arising from how sprawl develops and manifests
itself in different countries.
Comparative studies of geographic areas can be used
to examine the contributions of different risk factors to
specific cancers. For example, such studies have been
used to examine the relative contribution of environ-
mental exposures and reproductive characteristics to
breast cancer risk and the contributions of air pollution
versus smoking prevalence to lung cancer [22,23]. There
is also interest in urban–rural differences and spatial
variation in stage at diagnosis. For example a study using
SEER data reports that urban as opposed to rural residenceis associated with stage at diagnosis for lung and colorectal
cancer [26] and there is also substantial geographic vari-
ation late stage breast and colorectal cancer diagnosis
[27,28]. Access to care and the distribution of race-ethnic
groups are associated with county level variation in stage
at diagnosis identified in some of these studies, but con-
siderable unaccounted for variation between counties
remains. Despite their limitations, ecological analyses or
cross case comparisons are sometimes one of the best
and most feasible ways to examine the contributions of
environmental and contextual variables to health out-
comes and to identify targets for focused intervention
studies [28-31].
The main goal of this paper is to examine cross-
sectional associations between urban sprawl and cancer
mortality, accounting for spatial variation in mortality
and the effects of obesity, smoking, measures of health
care services and access, and socioeconomic status. Be-
cause obesity is a risk factor for cancer at a number of sites
[32] and because the prevalence of obesity is greater in
more sprawling regions of the US [4], we hypothesized
that mortality for obesity related cancers would be higher
in more sprawling areas. In addition to its association with
obesity prevalence, sprawl may also have an effect on
access to care. For example; increased travel time could
influence access to screening and treatment facilities
[33]. Thus our overall conceptual model involves a socio-
ecological approach and includes urban form, modifiable
risk factors, and demographic variables, as well as mea-
sures related to care. In this paper we chose to examine
associations between urban sprawl and obesity-related
cancer mortality. Future studies could address specific
cancers, cancer related to other risk factors such as
smoking, and cancer incidence.
Our analysis emphasizes the potential role of urban
sprawl as an influence on obesity related cancer because
of the extensive literature exploring the association
between the built environment and energy balance that
has appeared over the past decade [4,5,13]. However, re-
cent reviews also suggest that the relationship between
obesity and environmental variables is heterogeneous,
with a lack of consistent associations across studies
[7,34,35]. Few past studies of urban sprawl have exam-
ined geographic differences in the association between
sprawl and health or health behaviors [12,36,37] and
therefore residual spatial heterogeneity associated with
such differences could account for some of the incon-
sistency seen in studies of the environment, health and
energy balance.
A further goal of this paper is to improve upon previous
approaches to the analysis of ecological data so that the ef-
fects of spatial autocorrelation are accounted for properly.
Spatial autocorrelation, a form of spatial dependency, oc-
curs when observations that are closer together in space
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and national variation in cancer incidence and mortality do
not explicitly address this issue [12,38], despite the consen-
sus amongst spatial statisticians that it is critical to account
for spatial dependency to obtain valid analytical results
[39]. Instead most past studies emphasize the standard
statistical assumptions of regression models such as inde-
pendence, normality, and homoscedasticity of error.
In light of these goals, the specific aims of this paper
are to 1) analyze associations between urban sprawl and
cancer mortality in the US and to determine to what
extent these associations differ in different regions of
the country and 2) more comprehensively assess and
address the presence of spatial autocorrelation in these
mortality data. We focus on cancer mortality rather
than incidence because urban sprawl has the potential
to influence determinants of both cancer incidence
and mortality via its relationships to risk factors such
as obesity and physical activity and via its influence on
factors related to cancer prevention and treatment
such as transportation and the distribution of facilities.
Methods
This cross-sectional analysis is based on 2002–2006
county level estimates of cancer mortality in the United
States of America from the US Surveillance, Epidemiology
and End Results (SEER) program [40], along with data ori-
ginating from the National Center for Health Statistics
[41]. We report results for men and women separately
for cancer mortality from the 19 and 21 most common
cancers in men and women respectively, and for six
cancers for which obesity is a major risk factor.
The geographic coverage of this analysis included 935
urban and suburban counties in the US (Figure 1). These
counties represent the complete set of continental US
counties of interest because the concept of urban
sprawl is not relevant in rural counties. They include
all metropolitan statistical areas in the continental
United States as defined by the US Census bureau and
adjacent (‘suburban’) counties. Variables used in our
analysis are summarized below and in Table 1. We also
used Census Division as a variable in our analyses to
explore regional variation in associations between
sprawl and mortality. The US census divides the nation
into nine contiguous divisions in four regions (Northeast
(New England and Middle Atlantic), Midwest (East and
West North Central), South (South Atlantic, East and
West South Central), and West (Mountain and Pacific)).
The divisions contain from three to eight states [42]. Our
sample included 34 to 222 counties per division.
Cancer mortality
County level mortality rates based on data from 2002–
2006 for the 19 most common cancers in adult males(oral cavity and pharynx, esophagus, stomach, colon,
liver, pancreas, larynx, lung, melanoma, bladder, kidney,
brain, thyroid, Hodgkin’s lymphoma, Non-Hodgkin’s
lymphoma, myeloma, leukemia, prostate and testis) and
the 21 most common cancers in adult females (similar
to the list for males except prostate and testis cancer are
replaced with cancer of the cervix, uterus, ovary and
breast) were obtained from the SEER database [43].
These cancers were selected because they were suffi-
ciently common to allow stable mortality estimates for
all the counties considered. After exploratory analyses of
mortality from specific cancers, we chose to analyze
mortality rates in two categories: overall cancer mortality
and obesity-related cancer (colon, endometrium, kidney,
esophagus, pancreas, post-menopausal breast). Obesity
related cancers were categorized based on the World
Cancer Research Fund [32] report on risk factors.
Breast cancer mortality was divided into pre and post-
menopausal on the basis of age, with breast cancer
mortality in women > 50 years old assumed postmeno-
pausal. No attempt was made to distinguish risk factors
for squamous cell versus adenocarcinomas. All rates were
directly age-adjusted using the 2000 U.S. population
standard.
Results for one county, Madison County, MS, were
excluded from regression analyses but included in the
summary tables. In Madison County, both male and
female cancer mortality rates for all cancers combined
were > 6 SD from their respective means of the 935
counties considered. A non-profit group, the Susan G.
Komen Foundation, previously identified Madison county
as having very high cancer mortality rates and the Centers
for Disease Control and Prevention (CDC) has attributed
these high rates to the presence of a hospice serving all
of central Mississippi [44]. Discussion with SEER staff
yielded no further clues as to alternative explanations as
to why this county had such high rates.
Sprawl index
The urban sprawl index used here is a composite measure
of features of urban form related to population density
and street accessibility [4]. In brief, the index, which arrays
counties from least to most sprawling, has its highest
values in urban counties such as the four urban boroughs
of New York City or San Francisco County, and its lowest
values in the suburbs of sprawling metropolitan regions
throughout the country [4,45]. Because of this inverse
scaling, some readers may find it easier to think of this as
a ‘compactness’ index [46]. Jackson County, adjacent to
Topeka KS, had the greatest level of sprawl in this data
set. The index is based on six variables extracted from US
census data - 1) Gross population density in persons per
square mile, 2) Percentage of population living at densities
less than 1,500 persons per square mile (low suburban
Figure 1 County level distributions of A) total cancer mortality (2002–2006), B) obesity (2007) and C) urban sprawl (2000) by tertiles
for the continental United States.
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greater than 12,500 persons per square mile (transit-
oriented urban density, 4) net urban density (the ratio
of population to urbanized land area from US census
data), 5) Average block size in square miles, and 6) Per-
centage of small blocks, roughly 500 feet on a side. The
first four of these variables are related to population
density and the remaining two variables are related to
block characteristics and street connectivity. For this
paper, the sprawl index was calculated based on US
Census data from 2000.Obesity
County level obesity prevalence estimates are based on
self reported height and weight summarized by the
CDC. Estimates for each county are based on Bayesian
analysis combining information from the US Behavioral
Risk Factor Surveillance System (BRFSS) and the US
Census [47,48].Smoking
Estimates of county level current smoking prevalence for
men and women during 2000–2003 were downloaded
from the National Cancer Institute (NCI) Division of
Cancer Control and Population Sciences (DCCPS) small
area estimates web page [49]. These prevalence estimates
were calculated using information from the National
Health Interview Survey (NHIS) and the BRFSS using
a model-based estimation procedure [50]. Note that
this estimation procedure uses covariates such as race/
ethnicity, age, and education levels. Some of these
covariates are also used in our analysis.Race/ethnicity data
County level prevalence of self-identified Non-Hispanic
White, Non-Hispanic Black, Hispanic and American
Indian, Asian, and Pacific Islander (AIAPI) race/ethnic
groups were obtained from the 2000 US Census. Preva-
lence of American Indian, Asian and Pacific Islander
Table 1 Distributions of covariates and cancer
mortality rates
Variable* Mean (SD) Minimum Maximum
Cancer mortality rates
Females
All cancers 242.2 (27.5) 145.4 354.8
Obesity related 102.4 (16.0) 43.9 168.2
Males
All cancers 242.0 (34.2) 123.3 361.6
Obesity related 56.4 (8.8) 5.2 96.6
Sprawl index
Continental US 100 (25) 62 479
New England (N = 34) 108 (24) 79 213
Middle Atlantic (N = 89) 122 (59) 80 479
East North Central (N = 168) 97 (14) 68 171
West North Central (N = 92) 94 (14) 62 132
South Atlantic (N = 222) 95 (16) 66 188
East South Central (N = 91) 92 (11) 68 116
West South Central (N = 123) 99 (13) 74 166
Mountain (N = 50) 103 (12) 79 130
Pacific (N = 65) 113 (24) 85 258
Other covariates
Obese (%)** 27.3 (3.6) 12.4 40.9
Current smokers (%)
Female 21.9 (4.8) 7.9 36.9
Male 25.7 (5.0) 12.0 41.3
Non-hispanic white (%) 82.9 (14.3) 21.2 99.0
Non-hispanic black (%) 9.9 (12.6) 0.0 70.7
Hispanic (%) 6.7 (11.1) 0.28 94.4
American Indian/Asian PI (%) 2.5 (4.9) 0.0 55.2
MD density*** 2.0 (1.8) 0.0 20.1
Hospital density*** 0.021 (0.018) 0.0 0.15
Uninsured**** 14.1 (4.4) 6.7 36.8
Socioeconomic position index 0.64 (0.8) −1.67 1.89
*N = 935 for covariates, N = 934 for cancer mortality rates.
**Age adjusted% BMI ≥ 30.
***(Number/County Population)*10,000.
****Under 65 Years old.
Age-adjusted cancer mortality rates were obtained from the NCI SEER Cancer
Registry (2002–2006) by averaging county values.
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excluded American Indians gave qualitatively similar
results (not shown).
Socioeconomic position index
We calculated a version of the Krieger 2002 Socioeco-
nomic Position Index (SEP) index [51] for each county.
The SEP represents a summary deprivation measure
consisting of a standardized z score combining data onpercentage working class, unemployment, percentage
below US poverty line, low education, expensive homes,
and median household income. Our version of the
index was based on a single principal component from
the Principal Components Analysis (PCA) of the six
variables considered. Higher values of the index indicate
higher socioeconomic position. For example, the five
counties with the lowest values of the SEP are Tunica
MS, Hidalgo, Cameron, and Webb Counties (TX), and
Terrell County (GA) whereas the five counties with the
highest values of SEP are Douglas CO, Loudon VA,
Hamilton IN, Howard MD, and Johnson County KS.
Access and availability of care
Information concerning physician density, hospital density,
and health insurance coverage were used as proxies for
access and availability to health care resources [33].
These variables were extracted from the 2008 release of
the Area Resource File (ARF) for the year 2002 [52].
Total active non-federal and federal physicians and
number of hospitals per 1000 people in the county were
selected for analysis. Prevalence of uninsured aged 0–64
was also calculated from ARF health care and Census
population data. Because prevalence of health insurance
coverage was positively associated with cancer mortal-
ity, contrary to many results at the individual level [53],
we also extracted median age of adults from census data
in order to determine if residual variation in age structure
accounted for the ecological association of insurance
prevalence and cancer mortality (It did not, see below).
Statistical analysis
We used SAS JMP and R to initially examine the associ-
ation between cancer mortality and the independent vari-
ables listed above and to check that the data met the
assumptions required of the proposed linear regression
models [54,55]. The age-adjusted mortality rates were
approximately normally distributed so no data transform-
ation of the rates was necessary. Variables relating to race/
ethnicity, physician (MD) density, hospital density, and the
sprawl index were natural log transformed to improve the
linearity of their associations with mortality. Additionally,
cancer mortality rates were weighted by county population
size in order to stabilize their variances for large and small
counties, an assumption also required by the subsequent
models. Separate models were fit for males and females
and for both of the cancer groupings.
Our overall approach involved fitting an increasingly
complex series of normal linear regression models to the
age-adjusted mortality rates and then examining to what
extent adding more explanatory covariates, interactions
and spatial autocorrelation accounted for the observed
variation in mortality rates. Important two way interac-
tions between the main effect covariates were identified
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a weighted average of the least absolute shrinkage and
selection operator (LASSO) and Ridge regression variable
selection methods [56]. This method has been shown to
be more robust than conventional stepwise regression
variable selection methods and overcomes problems of
selection from among highly correlated variables by either
the LASSO or Ridge methods alone [56,57]. Interactions
from this initial variable selection process were retained in
the subsequent regression models only if they were sig-
nificant (p value < 0.05) Because the Elastic Net method
evaluates groups of the covariates and interactions, un-
like stepwise regression methods, no further adjustment
for multiple comparisons was needed. Note that final
models included different interactions for the different
gender and cancer groupings.
As noted above, our main study aim involved under-
standing the relationship between urban sprawl and can-
cer mortality. Therefore, we began by examining simple
models estimating the relationship between mortality
and urban sprawl without any other covariates. For each
of the four groups (Overall and obesity related cancer
mortality by gender) six models were fit and examined
for the presence or absence of spatial auto-correlation.
These models included successively more variables related
to cancer causes and spatial structure: Model 1: ln sprawl,
Model 2: ln Sprawl + demographic and other covariates,
Model 3: ln Sprawl + demographic and other covariates +
Census Division, Model 4: ln Sprawl + demographic and
other covariates + interactions + Census Division, Model 5:
ln Sprawl + demographic and other covariates + interac-
tions + Census Division + random effects to account for
county-level spatial autocorrelation, Model 6: ln Sprawl +
demographic and other covariates + interactions + Census
Division + County random effects + ln Sprawl*Census
Division interaction.
All models were implemented using SAS PROC
GLIMMIX [58] by pseudo-likelihood estimation with
population weights. For the spatial autocorrelation
models, a spatial variance component was included as a
random effect on the linear predictor (in SAS terms, a
G-side effect). This parameter was estimated by a spline
smoothing algorithm over a regular grid that spanned
the continental US, i.e., with spatial autocorrelation based
on distances between all pair-wise county locations. Loca-
tion was defined by latitude and longitude of the county
geographic centroids. Broad regional spatial patterns were
assessed by inclusion of indicator variables for Census
Divisions as fixed effects in the models.
Because there is no single statistic, such as a likelihood
ratio statistic, that adequately measures the goodness of
fit of spatial mixed effects models, we examined fit using
several different techniques [39,59]. A standard set of re-
sidual plots was generated for each model and examinedfor model fit and consistency with distributional assump-
tions. We also examined overall fit of the models by tabu-
lating pseudo R2 and Akaike’s Information Criterion (AIC)
values. The pseudo R2 statistic measures the proportion of
total variance explained by the model (1-(sum of squared
errors)/(total sum of squares)). AIC is a measure of the re-
gression sum of squares that includes a penalty for every
added covariate [60]. The “best” of the 6 models is the one
with the highest R2 and/or the lowest AIC value.
Because one of our objectives was to explore the extent
to which these models accounted for spatial patterns
and autocorrelation in mortality rates, we also calculated
Moran’s I statistic for the standardized residuals of the six
models described above using a one-sided permutation
test [39]. This statistic does not account for variation in
rates due to population differences, so we used it to rank
the degree to which each model reduced the spatial pat-
terns apparent in the original data. Successive efforts to
account for spatial effects involved models with a) our
complete set of covariates to explain spatial patterns at the
county level, b) inclusion of US Census Division to explain
broader regional patterns, and c) spatial random effects to
account for any remaining spatial autocorrelation, i.e., the
tendency of mortality rates for neighboring counties to be
similar. All of these three elements were required to ad-
equately account for the spatial patterns and autocorrel-
ation in the data. We included the interaction term
between our measure of sprawl and Census Division in
our final models because it represents an explicit test of




Characteristics of the 935 counties studied here and
mortality rates for the cancers examined are presented
in Table 1. Note that the mean and standard deviation of
the sprawl (‘compactnessʼ) index (100, 25) reflect the
standardization procedure used to develop the index [4].
Obesity prevalence and the sprawl index used here were
negatively associated (r = −0.36), this indicates lower
prevalence of obesity in less sprawling areas because a
higher sprawl index corresponds to a denser more urban-
ized county. Overall, US counties exhibit a wide range of
values for all the variables used in our analyses.
The twelve variables considered in this analysis are
mostly weakly correlated with one another. The strongest
correlation (0.79), between male and female smoking
prevalence, represents two variables that are not included
in the same models. The second strongest correlation
(−0.71) was between proportions of non-Hispanic whites
(Treated as the reference group in our models) and blacks.
There were statistically significant positive correlations
from 0.52- 0.62 between the prevalence of obesity and
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sprawl index and the proportion of American Indian,
Asian and Pacific Islanders (AIAPI) and physician density
and between the proportion Hispanic and AIAPI. Thus,
the proportion of AIAPI was greater in more urban areas.
There were significant negative correlations (−0.52—0.56)
between prevalence of smoking in females and the pro-
portion Hispanic and AIAPI and between current smok-
ing in males and the SEP. The remaining 66 correlations
were not statistically significant. The modest correlations
among most of the variables suggest that we have identi-
fied a robust set of county level characteristics.
Cancer mortality rates for the four groupings we ex-
amined showed substantial variation at the county level
(Table 1). The range of mortality rates for cancer related
to obesity varied by four-fold in females and by almost
20-fold in males among counties and rates for overall
cancer mortality varied by 2–3 fold. Geographic distribu-
tions of the urban sprawl index, overall cancer mortality
for both sexes combined and the prevalence of obesity
are illustrated in Figure 1A-C. Note that multiple urban
and suburban counties are found in every state in the
continental U.S.
Spatial autocorrelation
To determine if our simple models accounted for spatial
autocorrelation in cancer mortality rates across these
935 urban and suburban counties, we calculated Moran’s
I statistic for a series of models for both genders and the
two cancer groups of interest (Table 2). Analysis of
residuals from the simplest models (ln Sprawl only) for
all four of our cancer mortality groupings and two of the
more complex models for females showed highly signifi-
cant unexplained spatial autocorrelation (Table 2). The
addition of random effects to capture spatial autocorrel-
ation of rates at the county level reduced all Moran’s ITable 2 Moran’s I test for spatial autocorrelation for alternati




1. ln sprawl 0.099 ≤0.0001
2. ln sprawl + other covariates −0.005 0.999
3. ln sprawl + other covariates + census divisions −0.003 0.992
4. ln sprawl + other covariates + census divisions
+ selected interactions −0.003 0.986
5. ln sprawl + other covariates + census divisions
+ selected interactions + county centroids −0.002 0.91
6. ln sprawl + other covariates + census divisions
+ selected interactions + county centroids
+ ln sprawl * census division interaction −0.002 0.827
Values in bold are associated with significant Moran’s I, p < 0.05.values to non-significant levels (Table 2, models 5 & 6).
Furthermore, the spatial variance component parameters
measuring autocorrelation across counties were signifi-
cant in the most complex models for overall cancer
among both men and women and obesity-related can-
cers among men. Together these results suggest that the
simple fixed effects models did not adequately account
for spatial patterns in the residuals. In subsequent
models we included census divisions to measure broad
regional effects and a random effect for spatial autocor-
relation between counties. After inclusion of these vari-
ables in the models there is little spatial variation in
mortality rates that is not explained by the specific
demographic, risk, and health care related factors and
location effects included in the more complex analyses.
This allows us to perform a robust analysis of associa-
tions between urban sprawl and cancer mortality.
Model results
Preliminary analyses indicated that associations between
mortality and the sprawl index varied significantly by
Census Division. Therefore, we chose to include this
interaction term (ln sprawl*Census Division) in the final
random effects models presented here. Coefficients for
the main effects of the nine covariates in addition to
urban sprawl included in each model are given in Table 3
and coefficients for Census Division and ln sprawl*Census
Division are presented in Table 4. Because the interactions
between census division and natural log transformed
sprawl index were significant, we do not report overall
coefficients for the sprawl index.
We found significant interactions between the natural
log (ln) transformed sprawl index and Census Division
for all four groupings (Table 4), in other words, the slope
of the association between this urban sprawl index and
cancer mortality rate differed in different parts of theve models
cers Obesity related cancers
Female Male Female
I p I p I p
0.049 ≤0.0001 0.067 ≤0.0001 0.039 ≤0.0001
0.004 0.005 −0.006 0.999 −0.0001 0.154
0.001 0.051 −0.001 0.487 −0.0006 0.231
0.002 0.022 −0.002 0.669 0.002 0.03
−0.002 0.588 −0.002 0.687 −0.001 0.436
−0.002 0.792 −0.002 0.687 −0.002 0.767
Table 3 Random effects model results
All cancers Obesity related
Coefficients SE Coefficients SE
Females**
Current smoking 224.21* 20.2 85.85 12.75
Ln hispanic 0.55 1.1 −0.22 0.58
Ln NH black 10.50 1.0 6.62 0.62
Ln AIAPI −3.31 1.2 −1.42 0.71
Ln MD density 5.35 1.5 1.00 0.88
Ln hospital density −2.73 1.9 −1.77 1.11
Obesity 0.04 0.2 −0.02 0.16
SEP index 5.85 2.3 5.30 2.63
Uninsured −60.89 24.1 37.52 31.85
AIC 8238 7124
Gener. chi-square/df 49474989 16970961
Males
Current smoking 207.90 20.95 34.96 6.64
Ln hispanic 0.06 1.13 −0.33 0.35
Ln NH black 4.02 1.07 1.32 0.33
Ln AIAPI −5.22 1.26 −1.31 0.40
Ln MD density 4.48 5.05 −0.37 1.62
Ln hospital density 3.0 1.89 0.31 0.61
Obesity 1.26 0.29 0.22 0.09
SEP index 3.84 2.56 0.76 0.78
Uninsured −140.89 24.06 −35.24 7.60
AIC 8165 6125
Gener. chi-square/df 45146764 4801908
*Coefficients in bold are significantly different from zero, p ≤ 0.05.
**Interactions Included in the models were statistically significant with
p ≤ 0.01. For males: All cancers; MD*SEP, SEP*CD, MD* CD, and 2) Obesity
related cancers; MD*SEP, SEP*CD, MD*CD, and for females: 1) All cancers:
MD*SEP, SEP*CD and 2) Obesity related cancers: Smoking*SEP, Black*SEP,
MD*SEP, SEP*CD, Uninsured*CD, Note that the variables name above are
abbreviated MD = Physician density, CD = Census Division,
SEP = Socioeconomic Position, NH = Non-Hispanic, and ‘Ln’ (natural log) has
been removed.
Results for Census Division (CD) and CD*ln Sprawl are given in Table 4.
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lated cancers and the urban sprawl index are given in
Figure 2. For females, the interaction terms for census
division and ln sprawl for obesity related cancer mortality
were statistically significant for the East North Central
States, South Atlantic States, and East and West South
Central States. For males, the interaction term was signifi-
cant in the Mid-Atlantic, East North Central, and East
South Central Census Divisions and marginally significant
in the Pacific Division. Six of the seven statistically sig-
nificant interactions were positive, with a negative asso-
ciation in males in the Mid-Atlantic division. In other
words, obesity related cancer mortality rates were gen-
erally higher in less sprawling counties (Figure 2A,B).Current smoking was significantly and positively asso-
ciated with mortality for all four groups examined
(Table 4). The associations were strongest for total can-
cer mortality. Total cancer mortality for both genders
was higher in counties with greater prevalence of non-
Hispanic blacks, higher prevalence of obesity, and lower
where prevalence of American Indians and Asian and
Pacific Islanders was greater. A higher SEP was associ-
ated with total cancer mortality in females, but not in
males. For obesity related cancers, physician and hospital
density were negatively associated with cancer mortality
in males but not in females. Prevalence of uninsured
under age 64 was negatively correlated with all cancer
mortality in both sexes. We discuss this counterintuitive
result below.
Interactions included in our final models (Table 3)
were all statistically significant (p ≤ 0.01). For males, a
total of six interactions were included across the four
cancer groupings, all including Census Division, physician
density or both. For females, seven interactions were in-
cluded; all seven of these included Census Division, SEP
or both. Because our main interest here is in urban sprawl,
we do not present detailed results for these interactions;
nevertheless, they further highlight the presence of
regional heterogeneity in cancer mortality rates at the
Census Division level.
To assess goodness of fit, we report AIC and pseudo
R2 values in Table 5. AIC values were lowest in our final
models in all cases and R2 values were highest or nearly
highest (Table 5). Thus, all measures of model fit, in-
cluding Moran’s I statistic, support our choice of models
with Census Division, its interaction with sprawl and
spatial autocorrelation random effects included in the
models.
Discussion
This cross-sectional ecological analysis of urban sprawl
and cancer mortality was designed to examine associa-
tions between cancer mortality and urban sprawl and to
determine if such associations differed in different regions
of the United States. The study had two main results.
First, obesity related cancer mortality rates are either
higher in counties with less sprawling urban form or
unrelated to sprawl. This result extends a recent ana-
lysis by Fan and Song [12] that reported positive associ-
ations between total cancer mortality and sprawl in a
subset of the suburban counties examined here and also
reported higher mortality associated with cancer in
urban compared to suburban counties. Considerable
literature has also examined rural–urban differences in
mortality, with mixed results [24,61]. Some studies have
also reported risk of diagnosis at later stages of cancer is
higher in urban compared to rural or suburban areas
[19,26]. More specific measures of factors varying along
Table 4 Model results for census divisions and sprawl,
controlling for factors listed in Table 3
All cancers Obesity related
Census division* Coefficients** SE Coefficients SE
Females
Intercepts 346.5 79.1 126.2 26.6
Census divisions
1 New England −250.4 74.5 −95.9 44.0
2 Mid-Atlantic −4.0 44.3 −26.1 23.0
3 East North Central −265.3 53.9 −97.6 29.0
4 West North Central −109.1 82.8 −45.6 50.3
5 South Atlantic −199.0 56.4 −98.8 30.3
6 East South Central −307.4 105.2 −208.6 66.3
7 West South Central −239.8 75.1 −154.5 42.1
8 Mountain 39.4 118.9 13.2 65.5
9 Pacific (Reference) 0 0
Ln Sprawl*Census Division
1 New England 13.8 13.5 12.4 9.4
2 Mid-Atlantic −32.6 5.7 −2.3 3.1
3 East North Central 23.7 9.1 11.1 5.2
4 West North Central −7.6 16.6 0.4 9.7
5 South Atlantic 8.0 9.9 14.0 5.4
6 East South Central 32.1 22.0 35.9 13.4
7 West South Central 21.7 14.7 27.0 8.8
8 Mountain −41.4 24.1 −15.5 13.5
9 Pacific −29.9 8.3 −8.4 4.4
Males
Intercepts 209.7 128.5 14.3 27.9
Census divisions
1 New England −222.9 101.3 −39.2 30.6
2 Mid-Atlantic 121.8 59.3 55.8 18.1
3 East North Central −197.7 68.9 −53.4 21.1
4 West North Central −183.1 104.4 −6.7 32.9
5 South Atlantic −68.8 70.3 7.8 21.9
6 East South Central −484.2 151.6 −192.2 48.2
7 West South Central 15.9 97.5 −22.7 30.5
8 Mountain −78.4 126.5 −23.9 39.4
9 Pacific (Reference) 0 0
Ln Sprawl* Census division
1 New England 21.1 19.02 10.9 5.7
2 Mid-Atlantic −50.9 6.6 −8.4 2.1
3 East North Central 19.9 10.8 15.4 3.4
4 West North Central 20.3 20.8 5.8 6.6
5 South Atlantic −7.4 11.2 1.6 3.6
6 East South Central 87.4 31.9 46.5 10.2
7 West South Central −18.7 18.7 10.0 5.9
Table 4 Model results for census divisions and sprawl,
controlling for factors listed in Table 3 (Continued)
8 Mountain 0.5 24.9 10.7 7.8
9 Pacific −11.5 11.4 7.0 3.5
*States contained in the US Census Divisions are available at [42].
**Coefficients in bold are significantly different from zero, p ≤ 0.05.
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sprawl (‘compactness’) index examined in this paper
could help clarify how mortality and stage at diagnosis
are associated with features of such environments.
Second, the association between urban sprawl and
obesity related cancer mortality differs in different regions
of the United States, with more positive associations in
the southern part of the country and the Great Lakes area
for females and the central part of the US for males
(Table 3; Figure 2). Obesity related cancer mortality was
higher in more sprawling counties in the Mid-Atlantic
States for males. The least sprawling county in the US
(New York County NY) has a sprawl index of ~480
(natural log = 6.17) whereas Montgomery County, MD,
adjacent to Washington DC, a county with an inter-
mediate level of sprawl, has a sprawl index of ~120 (nat-
ural log = 4.79). The most sprawling counties in the US,
have indices of ~ 70 (natural log = 4.25). Thus, large
differences in urban form are associated with modest
differences in cancer mortality.
Nevertheless, these associations between sprawl and
cancer mortality could have public health significance
because of the large number of people involved. Greater
than 70% of the US population lives in the urban and
suburban counties analyzed here. The association between
obesity related cancers and sprawl was not qualitatively al-
tered by the inclusion of county level obesity prevalence in
the model despite the presence of cross-sectional associa-
tions between obesity and urban sprawl found in several
past studies [4,5,7]. This suggests that the elevated mortal-
ity rates observed in less sprawling areas in the south and
Great Lakes regions could be caused by social, medical
care related, or risk factors not adequately accounted for
in our models rather than obesity prevalence.
Comparative studies of diverse countries concerning
the health and environmental consequences of sprawl
are lacking [25]. Recent studies have reported that active
transportation is more common amongst Canadian 12–
15 year olds residing in more sprawling areas [15] and in
a large study of Portuguese adults population density
was not associated with physical activity or BMI [62]. In
both the US and in other countries, analyses of rural–
urban differences in cancer mortality have had mixed
results [21-24,61,63]. Careful comparative studies of urban
sprawl and cancer incidence and sprawl across diverse


















































Figure 2 Model based estimates of the association between natural log-transformed sprawl (‘compactness’) index and obesity-related
cancer mortality for males (A) and females (B) from data for 934 urban and suburban counties in the United States. States included in
the census divisions are available at the US Census [42]. The length of each regression line reflects the range of observed values in the Divisions
(Table 1).
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health outcomes.
Strengths of this analysis include that we make a rigor-
ous attempt to account for spatial variation in cancer mor-
tality and in the distribution of cancer risk factors at the
county level across the United States. This effort involves
successive elaboration of our regression models plus
allowing for possible spatial autocorrelation among neigh-
boring counties. We argue that this is important, because
of the proliferation of ecological models that include
geographic variables, but fail to test whether or not they
account for spatial variation in the dependent variables
of interest [12,38].
Our finding that the association between sprawl and
cancer mortality varies by region suggests that future
analyses of the health effects of sprawl should formally
include analysis of regional differences. Most past studies
of sprawl and energy balance have not focused on regional
variation [3-5,9,64]. Recently, Troped et al. [36] reportedregional difference in associations between perceived built
environment and physical activity but associations be-
tween perceived crime and activity did not appear to differ
by region [36]. The analyses in our paper adjust for the
effects of demographic, economic and health care system
related variables. Additional explanations for the regional
heterogeneity observed in relations between sprawl,
mortality and behavior could also be sought through
consideration of regional differences in transportation
systems, built environment aspects of sprawl, climate
related factors, or inadequate control for residual con-
founding by risk factors included in our models. For ex-
ample, counties classified as urban or suburban in the
western United States included some very large counties
such as Coconino, Yuma and Pima Counties in Arizona,
San Bernardino County in California, and San Juan
County in New Mexico. Additionally, suburban counties
in some areas of the US are almost entirely residential,
whereas in the Midwest and Western United States,
Table 5 Model comparisons by cancer group
All cancers Obesity related
AIC* R2 AIC R2
Females
1. ln_sprawl 9298.40 0.0069 7968.52 0.0034
2. ln_sprawl + other covariates 8735.42 0.1953 7635.26 0.0749
3. ln_sprawl + other covariates 8599.35 0.1886 7518.19 0.0831
+ census divisions
4. ln_sprawl + other covariates 8517.52 0.1813 7303.8 0.1059
+ census divisions + interactions**
5. ln_sprawl + other covariates 8351.39 0.2764 7207.87 0.1318
+ census divisions + interactions
+ spatial autocorrelation
6. ln_sprawl + other covariates 8238.44 0.2769 7124.72 0.1379
+ census divisions + interactions
+ spatial autocorrelation +
ln_sprawl * census division interaction
Males
1. ln_sprawl 9678.69 0.1331 6977.84 −0.0027
2. ln_sprawl + other covariates 8748.26 0.5882 6558.02 0.1691
3. ln_sprawl + other covariates 8628.94 0.6149 6431.43 0.2227
+ census divisions
4. ln_sprawl + other covariates 8511.83 0.6125 6367.28 0.2346
+ census divisions + interactions**
5. ln_sprawl + other covariates 8287.08 0.6878 6238.89 0.2948
+ census divisions + interactions
+ spatial autocorrelation
6. ln_sprawl + other covariates 8165.92 0.6913 6125.37 0.2994
+ census divisions + interactions
+ spatial autocorrelation +
ln_sprawl * census division interaction
*Akaike information criterion.
**Interactions included are described in Table 3 and the text.
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tural or undeveloped land. Nevertheless, our results
suggest that future geospatial analyses of cancer mortality
and urbanicity across the US should attempt to account
for regional variation in such associations and further
explore sources of such variation.
Insurance coverage by county
One ecological puzzle emerged from this analysis. We
found that the prevalence of lack of insurance coverage
in subjects under age 65 was negatively associated with
total cancer mortality rate in both males and females. In
other words, cancer mortality rates were lower in counties
where prevalence of insurance coverage was lower. Two
recent analyses using SEER mortality data concerningurological cancers (Prostate, Bladder, and Kidney) also re-
port negative associations between prevalence of unin-
sured and cancer mortality [38,65]. These results contrast
with a large body of evidence indicating that insurance
coverage decreases mortality rate at the individual level
[53]. Incomplete adjustment for age does not seem to ac-
count for this observation; inclusion of median age in our
regression models did not alter these findings, although
more detailed analysis of the potential effects of age struc-
ture may be necessary since everyone over 65 in the US is
covered by Medicare health insurance.
Heterogeneity in age, health and insurance coverage
among Hispanics may also account for the observed as-
sociation between lack of insurance coverage and lower
cancer mortality at the county level despite the inclusion
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models. Lack of insurance coverage and Hispanic race eth-
nicity are correlated at the county level in this data set and
the counties with high prevalence of uninsured and lower
cancer mortality are among the counties with the highest
proportion Hispanic. The Hispanic population also has a
younger age distribution that non-Hispanic Whites and
Blacks. However, the interactions between prevalence of
insurance and Hispanic race/ethnicity were not significant,
thus the associations observed here occurred independent
of each other. Furthermore, these counties span the whole
range of socioeconomic conditions as measured by the
SEP index. More attention to this ecological puzzle may
be warranted in light of the changes occurring in US
health care policy.
Study weaknesses
A significant weakness of this study is the reliance on
cross sectional data. A cross sectional analysis, such as
this one, cannot be used to draw causal inferences con-
cerning dependent variables. Nevertheless, we think that
our analysis is useful in that it draws attention to regional
heterogeneity in the association between sprawl and can-
cer mortality and supports a renewed focus on the higher
cancer mortality rates observed in urban areas. Addition-
ally, urban form changes slowly, therefore cross sectional
studies do have the unique ability to allow examination of
large differences in urban form.
Our analysis lacks information concerning two important
cancer related exposures. First, environmental exposures to
pollutants; such data are difficult to obtain in a uniform
format for this complete sample of urban and suburban US
counties. Exposure data might also be most relevant to
analyses of specific cancers and we hope the analytic
framework developed here will foster interest in pursuing
such analyses. Second, data concerning physical activity
and sedentary time. Sedentary behavior and physical activ-
ity are also associated with cancer incidence and mortality
at several sites [32]. Physical inactivity data based on self-
report are available at the county level [66]. However, we
chose not to include this potential covariate in part because
it is highly correlated with obesity prevalence, and in part
because of the limits of self reported PA data [67]. Self
report of obesity and smoking behavior are also subject to
measurement error, but these errors are better understood
than measurement error in physical activity [68,69]. Lack
of information about physical activity and environmental
pollutants could result in omitted variable bias if they are
part of a causal connection between urban sprawl and can-
cer mortality. Such omitted variable bias or unmeasured
confounders can influence regression results [70].
A potential weakness, but a difficult one to evaluate,
involves the fact that our county level estimates of BMI
and smoking are not actual measurements but the resultsof statistical models that include county demographic in-
formation also included in our models. This approach has
the potential to increase the correlations between some of
the explanatory variables in our models. However, because
the covariates used to improve estimates of county level
obesity and smoking prevalence are not strongly corre-
lated with the other demographic variables used in our
models, this problem may be a small one. Nevertheless,
our overall analysis would be more robust if we could use
estimates from data collected with sufficient accuracy in
the field or, if that is not possible, values that are not
contingent on these demographic variables [71,72].
Additional challenges involve the level of spatial aggre-
gation examined here and our use of a random effects
regression framework as opposed to a hierarchical linear
modeling approach [73] with levels of variance estimated
for several nested geographic areas. It is certainly not
obvious that county is the appropriate level of spatial
aggregation in which to examine cancer mortality rates
in relation to urban sprawl and the various covariates
considered in this analysis. Multilevel analysis that
accounted for individual as well as regional characteris-
tics could also be informative, for example by helping to
account for the unexpected direction of the association
between insurance coverage and mortality observed in
this analysis. Such analysis might also shed further light
on the observation that mortality rates for cancer were
higher in more urban areas. Analyses at different levels
of geographic aggregation and analyses incorporating
individual, as well as aggregate, variables are possible.
However, at present, US cancer mortality statistics are
publicly available only at the county level and death certifi-
cates do not include information on diverse cancer related
covariates at the individual level [43]. Furthermore, access
to the geocoded mortality data needed for such analyses
requires negotiation with each SEER registry site and
with the CDC. Thus significant barriers remain to more
complete and multi-level analysis of mortality data.
Conclusions
Urban sprawl appears to have diverse negative health
and environmental consequences. However, this study
demonstrates that the cross-sectional associations between
sprawl and mortality differ in different regions of the Uni-
tes States. Our results and those of other recent papers on
this topic [12,36] should encourage a more nuanced view
of the association between sprawl and health as well as fu-
ture studies that explore regional differences in the effects
of urban sprawl. More longitudinal studies of sprawl and
health [9,13] as well as multilevel analyses, regardless of
study design [11,37,74] will continue to clarify the poten-
tial for causal associations between urban form and health.
There are many existing cohort studies that would allow
such analyses.
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mortality rates in urban areas could help address dispar-
ities in cancer mortality. Preliminary results suggest that
there are also regional differences in the association
between urban sprawl and tobacco related cancer mor-
tality. Thus, future studies could examine tobacco-
related (oral cavity and pharynx, esophagus, larynx, lung,
bladder) cancers using a similar approach to the one
outlined here. Analyses of associations between sprawl
and cancer incidence are also a logical next step in an ef-
fort to identify specific factors increasing cancer mortality
in less sprawling urban and suburban counties both in the
US and potentially in other countries where sprawl has
emerged as a common pattern of development.
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